Abstract
Epithelial-mesenchymal transition (EMT) is a highly conserved and fundamental process in development, fibrosis, and metastasis. During the process, epithelial cells lose their morphology and transcriptional program, and transdifferentiate to mesenchymal cells. It has been reported that lens epithelial cells undergo EMT during cataract formation, and regulation of microRNAs on genes is associated with lens development. However, the molecular mechanisms of this regulation in diabetic cataract still need to be investigated. In the present study, the expression of E-cadherin was downregulated, while the expression of alpha-SMA and vimentin was upregulated in diabetic cataract tissues and the in vitro model, suggesting the involvement of EMT in diabetic cataract formation. Results of miRNA profiling demonstrated that miR-30a was markedly downregulated in diabetic cataract tissues. Overexpression of miR-30a-5p decreased SNAI1, a known modulator of EMT, and the expression of vimentin and alpha-SMA in our diabetic cataract model in vitro. It is concluded that EMT is involved in human diabetic cataract, and upregulation of miR-30a can repress EMT through its targeting of SNAI1 in lens epithelial cells, which make miR-30a a novel target of therapeutic intervention for human diabetic cataract.
Similar content being viewed by others
Introduction
Cataract or lens opacification is one of the major reasons causing visual impairment and blindness1. Diabetic cataract often occurs in earlier age of patients with high blood glucose and progresses fast2,3,4. Currently, the only treatment is to remove the opaque lens and implant a synthetic intraocular lens through surgery. It is significative to develop novel therapies for prevention and management of diabetic cataract.
Lens epithelial cells (LECs) are responsible for differentiation of lens fibers throughout the life of a lens. Correct differentiation and morphology of LECs maintain the normal transparency of the lens, while pathological changes in development, proliferation, differentiation, and apoptosis in LECs may lead to cataract5,6,7. The presence of epithelial-mesenchymal transition (EMT) during epithelial cell differentiation into fiber cells has been reported in the progress of cataract formation8,9,10,11,12,13. MicroRNAs (miRNAs) are a group of noncoding small RNAs and have been found to be associated with cell differentiation, proliferation, and apoptosis14,15,16. We previously detected that miR-204-5p could directly regulate EMT by targeting SMAD4 in posterior capsule opacification (PCO) known as a complication of cataract surgery17. In the study, an established capsular bag model cultured in vitro, which can faithfully recapitulate conditions in vivo, was employed.
Herein, we identified the ectopic expression of miR-30a in diabetic cataract lenses and further investigated the inverted regulation of miR-30a in demotion of EMT by targeting SNAI1 in LECs. Thus, we ascertained that miR-30a may play a role in the progress of diabetic cataract formation.
Results
Expression of miR-30a and EMT in human diabetic cataract LECs
In patients with diabetic cataract, opacity of lens subcapsular tissues was observed (Fig. 1A). By immunohistochemistry (Fig. 1B), the protein expression of E-cadherin was found to be higher in normal lens tissues (N) than in diabetic cataract tissues (DCa), while alpha-smooth muscle actin (alpha-SMA, a late marker of EMT) and vimentin showed a higher expression in DCa compared with N. Two normal samples (N1 and N2) and two diabetic cataract samples (DCa1 and DCa2) were used to perform Western blotting (Fig. 1C). The results revealed a decreased expression of E-cadherin in DCa1 and DCa2 and an increased expression of alpha-SMA and vimentin when compared to N1 and N2. Both immunohistochemistry and Western blot analyses suggested that EMT was a significant event in LECs of patients with diabetic cataract.
To investigate whether miRNAs were differentially expressed in normal and diabetic cataract LECs, a miRNA microarray analysis was performed using on capsular bags from three normal lenses (N3, N4, and N5) and three diabetic cataract lenses (DCa3, DCa4, and DCa5). Based on the pooled data from each group, the results showed that 73 miRNAs in the diabetic cataract LECs were unregulated more than two folds (N3, N4, and N5 as control), while 199 miRNAs were downregulated more than two folds. The expression of miR-30a-5p was downregulated 180-fold. The part of the heatmap is presented in Fig. 1D.
MiR-30a was further investigated because it was predicted to target SNAI1 associated with EMT. To confirm whether there was significant difference in the expression of hsa-miR-30a between the normal and diabetic cataract LECs, quantitative RT-PCR (qRT-PCR) was employed using the RNA of the miRNA microarray study. The hsa-miR-30a expression was downregulated significantly in the diabetic cataract LECs compared with the normal ones (P < 0.05, Fig. 1E). According to the bioinformatics database (available at http://www.targetscan.org/), miR-30a targets SNAI1 3′-UTR (706–713) (Fig. 1F).
Diabetic cataract model in vitro
The lens capsular bags were cultured in DMEM-F12 with 10% fetal bovine serum containing 5 mM D-glucose (normal glucose, NG), 25 mM D-glucose (high glucose, HG), or 5 mmol/L D-glucose plus 20 mmol/L mannitol (high mannitol, HM). The results of qRT-PCR in LECs showed that the expression of miR-30a-5p was increased in HG conditions (NG as control; P < 0.05, Fig. 2B). In the in vitro model, the expression of EMT markers was also detected by immunohistochemistry (Fig. 2C). The staining intensity of vimentin and alpha-SMA protein expression increased in HG compared to NG, suggesting that our diabetic cataract model in vitro adequately simulated the states in vivo.
MiR-30a targeted SNAI1 in the diabetic cataract model in vitro
A dual luciferase reporter assay was performed to test the direct link between miR-30a and SNAI1 (Fig. 3A). When pmiR-RB-REPORT-SNAI1-3′UTR and miR-30a mimic were cotransfected, the relative luciferase activity decreased significantly. Moreover, mutation of the perfectly complementary sites in the SNAI1-3′UTR abolished the suppressive effect of miR-30a. These results confirmed that miR-30a-5p could directly target and regulate SNAI1. In the in vitro model, the SNAIl mRNA and protein expression increased significantly in HG (NG as control, Fig. 3B and C). After the capsular bags were cultured in HG conditions for three days, they were transfected with a miR-30a mimic, inhibitor or negative control (NC). SNAI1 mRNA levels were significantly downregulated after transfection with the miR-30a mimic and upregulated after transfection with the inhibitor (Fig. 3D). Furthermore, Western blotting revealed that upregulation of miR-30a repressed the protein expression of SNAI1 in LECs, whereas downregulation of miR-30a enhanced the SNAI1 expression (Fig. 3E). Therefore, manipulating the expression of miR-30a-5p affected the expression of SNAI1 in the LECs in vitro.
The inverted regulation of miR-30a on EMT
To further investigate the role of miR-30a-5p in repressing EMT in the diabetic cataract model in vitro, protein levels of vimentin and alpha-SMA were detected. The expression of both vimentin and alpha-SMA proteins was downregulated after the capsular bags were treated with the miR-30a mimic (mimic NC as control, P < 0.05; Fig. 4A). Moreover, the capsular bags were treated with transforming growth factor-beta2 (TGF-beta2) and a miR-30a-5p mimic. In the TGF-beta2 group, alpha-SMA and vimentin were high expressed relative to the group without TGF-beta2 treatment, suggesting an increased EMT level induced by TGF-beta2. By contrast, upregulation of miR-30a decreased the alpha-SMA expression and vimentin expression (Fig. 4B). MiR-30a could downregulate the levels of EMT induced by HG and TGF-beta2 in the diabetic cataract model.
Discussion
Understanding of the functions of miRNAs on EMT in LECs could provide the means for discovering novel therapies for diabetic cataract. In the present study, miR-30a was observed to be downregulated in diabetic cataract tissues, and miR-30a-5p targeted SNAI1 and inhibited EMT by the SNAI1-dependent way in LECs in vitro.
In our previous study17, we found that miR-204-5p, miR-30a-5p, miR-204-3p, and miR-184 were significantly downregulated in PCO samples. PCO is a secondary cataract and occurs as an implication of cataract surgery, especially in congenital cataract cases. Although the pathogenesis of different types of cataracts is not well known, the converted expression of miRNAs in PCO gives a sight on diabetic cataract tissues. In the present study, the four miRNAs were also identified to have a low expression in diabetic cataract tissues through the miRNA microarray analysis. The qRT-PCR analysis demonstrated a more significant decrease of miR-30a-5p in diabetic cataract LECs. The expression levels of miRNAs showed partial similarity in capsular bag tissues between PCO and diabetic cataract according to our miRNA microarrays, and miRNAs performed diversified functions by targeting various genes17,18,19. MiRNAs have been reported to be associated with eye development and diseases, such as diabetic corneas19, primary angle closure glaucoma20, cataract formation21, and retinopathy22. Many upregulated mRNA transcripts were observed to be candidate targets of the miR-30 family according to the tubulointerstitial fibrosis and gene expression analysis23, suggesting that the miR-30 family could be involved in homeostasis. In a previous report, miR-30a was found to target SNAI1, inhibiting invasion and metastasis in non-small cell lung cancer24. Therefore, we investigated the role of miR-30a in the regulation of EMT in the diabetic cataract model in vitro. To our knowledge, this is the first study to show the importance of miR-30a in the inhibition of lens opacity in diabetic lenses.
EMT has been identified as a significant event in many fibrotic diseases and abnormal differentiation of LECs inducing the formation of cataract25. The current researches on EMT mostly focus on the aspect of PCO formation. In a mouse lens capsular injury model, the increased ability of motility and migration of LECs contributed to the formation of lens subcapsular plaque in the injured area13. MiR-181a was identified to affect the proliferation and migration abilities of LECs in PCO tissues and inhibit EMT in LECs by targeting c-Met, Slug, and COX-226. In addition, advanced glycation endproducts could enhance the TGF-beta2-mediated EMT during PCO and might participate in aging and diabetes-related fibrosis11. Although EMT was an obvious event in age-related cataract tissues27, the pathological role of EMT remains unknown in the formation process of diabetic cataract. As vimentin and alpha-SMA are commonly chosen as EMT markers28,29,30,31, over-productions of vimentin and alpha-SMA in diabetic cataract LECs were found in our study, suggesting that LECs were undergoing EMT in diabetic cataract development. Moreover, induction of SNAI1 expression was noted in majority of instances of EMT23, 32,33,34, and increased SNAI1 levels were correlated with cataract35, 36, indicating the important role of SNAI1 in EMT and cataract. In our study, we identified the reverted regulation of miR-30a on SNAI expression by transfecting the miR-30a mimic and inhibitor in LECs. TGF-beta2 has been found to be related to EMT and fibrosis in a number of tissues including ocular tissue, as well as PCO37, 38. In the present study, the downregulated expression of EMT markers by miR-30a in LECs was also shown in the presence of TGF-beta2 and HG conditions. We will continue our study on the potential therapeutic role of miR-30a to prevent or/and delay the progress of diabetic cataract.
In conclusion, we identified that EMT is involved in human diabetic cataract, and upregulation of miR-30a can repress EMT through its targeting of SNAI1 in lens epithelial cells, which make miR-30a a novel target of therapeutic intervention for human diabetic cataract.
Methods
Lens tissue sample collection
This study was approved by the institutional review board at the Shandong Eye Institute (Qingdao, China). All procedures were performed following the tenets of Declaration of Helsinki. Written informed consent was obtained from each diabetic cataract patient for the collection of samples in the process of cataract surgery by YH. Donor capsular bags were provided by the Qingdao Red Cross Eye Bank (Qingdao, China).
Human diabetic cataract model in vitro
The lens capsular bags were cultured as previously described17. Briefly, the capsular bags were put in DMEM-F12 with 10% fetal bovine serum containing 5 mM D-glucose (NG), 25 mM D-glucose (HG), or 5 mmol/L D-glucose plus 20 mmol/L mannitol (HM). After 3 days, they were transfected with a mimic, inhibitor or NC of miR-30a (Guangzhou RiboBio Co., Guangzhou, China) by using our previously reported method17. In brief, the miR-30a mimic, inhibitor or NC was mixed with lipofectamineTM 2000 (Invitrogen, Carlsbad, CA) to form miRNA-LipofectamineTM 2000 complexes. Subsequently, the complexes were added in the medium at a final concentration of 50 nM and incubated with the capsular bags for 6 hours. They were also treated with both TGF-beta2) (10 ng/ml) and a miR-30a-5p mimic.
MiRNA microarray analysis and quantitative RT-PCR
The miRCURYTM LNA array (v.18.0) (Exiqon, Vedbaek, Denmark) was used in this miRNA microarray study (KangChen Bio-tech, Shanghai, China). Three normal samples and three diabetic samples were allocated for this analysis. Total RNA was isolated using a miRNeasy mini kit (QIAGEN), and RNA quality and quantity was measured by using a nanodrop spectrophotometer (ND-1000, Nanodrop Technologies). The miRNA labeling was prepared using the miRCURY™ Hy3™/Hy5™ Power labeling kit (Exiqon), and miRCURYTM LNA array was performed according to the array manual. Scanned images were then imported into GenePix Pro 6.0 software (Axon) for grid alignment and data extraction. For quantitative RT-PCR, total RNA was isolated with a RNeasy micro kit (QIAGEN) from one capsular bag for each group. A MMLV first-strand synthesis kit (Lifetech) and a miRNA first-strand synthesis kit (Clontech, Dalian, China) were used to synthesize the ordinary and micro cDNA. The SYBR Green (Clontech) was used on an ABI 7500 system (Applied Biosystems). The primer sequences used were as follows: SNAI1 F′TTCAACTGCAAATACTGCAACA AG, R′CAGTGTGGGTCC GGACATG. hsa-miR-30a F′TGTAAACATCCTCGA CTGGAA.
Western blot analysis
Two capsular bags were homogenized in each group, and then the homogenates were assayed with SDS-polyacrylamide gels and transferred to polyvinyl difluoride membranes (Thermo Fisher Scientific). The membranes were stripped and probed with the following primary antibodies: anti-GAPDH (Kangchen), anti-SNAI1 (Abcam), anti-E-Cadherin (BD Transduction Laboratories), anti-Vimentin (Abcam), and anti-alpha-SMA (Abcam). Quantification of Western blots was processed with ImageJ.
Immunohistochemistry
After incubation with 5% BSA (Boster Biologic Technology) for 30 min at room temperature, paraffin sections of samples were incubated overnight with primary antibodies mentioned above, washed for 15 minutes, and stained with the IHC kit (MXB) at room temperature for 60 min. After washing, a color reaction was detected using a diaminobenzidine kit (ZS-BIO).
Luciferase activity assay
Human SNAI1-3′UTR containing the putative target site for miR-30a-5p was amplified by PCR and inserted into the pmiR-RB-REPORT (RiboBio), as well as the mutation. The cells were transiently transfected with the wild type or mutant reporter plasmids, miRNA mimic, and NC mimic using Lipofectamine 2000 (Invitrogen). Luciferase activity was measured 48 hours after transfection using the dual-luciferase assay system (Promega). Three independent experiments were performed in triplicate.
Statistical analysis
Each experiment was performed three times. For descriptive statistics, data are expressed as mean ± standard deviation. Analysis of differential expression was performed using an unpaired t-test. A P value of <0.05 was considered to be statistically significant.
References
Pascolini, D. & Mariotti, S. P. Global estimates of visual impairment: 2010. The British journal of ophthalmology 96, 614–618, doi:10.1136/bjophthalmol-2011-300539 (2012).
Harding, J. J., Egerton, M., van Heyningen, R. & Harding, R. S. Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies. The British journal of ophthalmology 77, 2–6, doi:10.1136/bjo.77.1.2 (1993).
Kahn, H. A. et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. American journal of epidemiology 106, 33–41 (1977).
Pollreisz, A. & Schmidt-Erfurth, U. Diabetic cataract-pathogenesis, epidemiology and treatment. Journal of ophthalmology 2010, 608751–8, doi:10.1155/2010/608751 (2010).
Worgul, B. V., Merriam, G. R. Jr. & Medvedovsky, C. Cortical cataract development–an expression of primary damage to the lens epithelium. Lens and eye toxicity research 6, 559–571 (1989).
Wang, Y., Zhang, G., Kang, L. & Guan, H. Expression Profiling of DNA Methylation and Transcriptional Repression Associated Genes in Lens Epithelium Cells of Age-Related Cataract. Cellular and molecular neurobiology, doi:10.1007/s10571-016-0393-9 (2016).
Su, D. et al. Down-regulation of GJA3 is associated with lens epithelial cell apoptosis and age-related cataract. Biochemical and biophysical research communications 484, 159–164, doi:10.1016/j.bbrc.2017.01.050 (2017).
Roy, H. K. et al. Down-regulation of SNAIL suppresses MIN mouse tumorigenesis: modulation of apoptosis, proliferation, and fractal dimension. Molecular cancer therapeutics 3, 1159–1165 (2004).
Willis, B. C. & Borok, Z. TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. American journal of physiology. Lung cellular and molecular physiology 293, L525–534, doi:10.1152/ajplung.00163.2007 (2007).
Zablocki, G. J. et al. Aldose reductase-mediated induction of epithelium-to-mesenchymal transition (EMT) in lens. Chemico-biological interactions 191, 351–356, doi:10.1016/j.cbi.2011.02.005 (2011).
Raghavan, C. T. et al. AGEs in human lens capsule promote the TGFbeta2-mediated EMT of lens epithelial cells: implications for age-associated fibrosis. Aging cell 15, 465–476, doi:10.1111/acel.12450 (2016).
Lovicu, F. J., Shin, E. H. & McAvoy, J. W. Fibrosis in the lens. Sprouty regulation of TGFbeta-signaling prevents lens EMT leading to cataract. Experimental eye research 142, 92–101, doi:10.1016/j.exer.2015.02.004 (2016).
Xiao, W. et al. Quantitative analysis of injury-induced anterior subcapsular cataract in the mouse: a model of lens epithelial cells proliferation and epithelial-mesenchymal transition. Scientific reports 5, 8362, doi:10.1038/srep08362 (2015).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297, doi:10.1016/S0092-8674(04)00045-5 (2004).
Zhang, B., Wang, Q. & Pan, X. MicroRNAs and their regulatory roles in animals and plants. Journal of cellular physiology 210, 279–289, doi:10.1002/jcp.20869 (2007).
Qin, Y. et al. MicroRNA-125b inhibits lens epithelial cell apoptosis by targeting p53 in age-related cataract. Biochimica et biophysica acta 1842, 2439–2447, doi:10.1016/j.bbadis.2014.10.002 (2014).
Wang, Y. et al. MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4. Investigative ophthalmology & visual science 54, 323–332, doi:10.1167/iovs.12-10904 (2013).
Zou, X. Z., Liu, T., Gong, Z. C., Hu, C. P. & Zhang, Z. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. European journal of pharmacology 796, 190–206, doi:10.1016/j.ejphar.2016.12.003 (2017).
Gao, J., Wang, Y., Zhao, X., Chen, P. & Xie, L. MicroRNA-204-5p-Mediated Regulation of SIRT1 Contributes to the Delay of Epithelial Cell Cycle Traversal in Diabetic Corneas. Investigative ophthalmology & visual science 56, 1493–1504, doi:10.1167/iovs.14-15913 (2015).
Shi, H. et al. Primary Angle Closure and Sequence Variants within MicroRNA Binding Sites of Genes Involved in Eye Development. PloS one 11, e0166055, doi:10.1371/journal.pone.0166055 (2016).
Li, Q. L. et al. MicroRNA-34a promoting apoptosis of human lens epithelial cells through down-regulation of B-cell lymphoma-2 and silent information regulator. International journal of ophthalmology 9, 1555–1560, doi:10.18240/ijo.2016.11.04 (2016).
Hou, Q. et al. LGR4 Is a Direct Target of MicroRNA-34a and Modulates the Proliferation and Migration of Retinal Pigment Epithelial ARPE-19 Cells. PloS one 11, e0168320, doi:10.1371/journal.pone.0168320 (2016).
Shi, S. et al. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. Journal of the American Society of Nephrology: JASN 19, 2159–2169, doi:10.1681/ASN.2008030312 (2008).
Kumarswamy, R. et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. International journal of cancer 130, 2044–2053, doi:10.1002/ijc.26218 (2012).
Taiyab, A., Korol, A., Deschamps, P. A. & West-Mays, J. A. beta-Catenin/CBP-Dependent Signaling Regulates TGF-beta-Induced Epithelial to Mesenchymal Transition of Lens Epithelial Cells. Investigative ophthalmology & visual science 57, 5736–5747, doi:10.1167/iovs.16-20162 (2016).
Dong, N., Tang, X. & Xu, B. miRNA-181a inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells. Investigative ophthalmology & visual science 56, 993–1001, doi:10.1167/iovs.14-15860 (2015).
Wei, J. et al. Expression and function of PDGF-alpha in columnar epithelial cells of age-related cataracts patients. Genetics and molecular research: GMR 14, 13320–13327, doi:10.4238/2015.October.26.28 (2015).
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature reviews. Molecular cell biology 3, 349–363, doi:10.1038/nrm809 (2002).
Saika, S. et al. Smad translocation and growth suppression in lens epithelial cells by endogenous TGFbeta2 during wound repair. Experimental eye research 72, 679–686, doi:10.1006/exer.2001.1002 (2001).
Saika, S. et al. Immunolocalization of prolyl 4-hydroxylase subunits, alpha-smooth muscle actin, and extracellular matrix components in human lens capsules with lens implants. Experimental eye research 66, 283–294, doi:10.1006/exer.1997.0434 (1998).
Serini, G. & Gabbiani, G. Mechanisms of myofibroblast activity and phenotypic modulation. Experimental cell research 250, 273–283, doi:10.1006/excr.1999.4543 (1999).
Peinado, H., Olmeda, D. & Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature reviews. Cancer 7, 415–428, doi:10.1038/nrc2131 (2007).
Takkunen, M. et al. Snail-dependent and -independent epithelial-mesenchymal transition in oral squamous carcinoma cells. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society 54, 1263–1275, doi:10.1369/jhc.6A6958.2006 (2006).
Usami, Y. et al. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. The Journal of pathology 215, 330–339, doi:10.1002/path.2365 (2008).
Li, P. et al. RNA Interference Targeting Snail Inhibits the Transforming Growth Factor beta 2-Induced Epithelial-Mesenchymal Transition in Human Lens Epithelial Cells. Journal of ophthalmology 2013, 869101, doi:10.1155/2013/869101 (2013).
Cho, H. J., Baek, K. E., Saika, S., Jeong, M. J. & Yoo, J. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochemical and biophysical research communications 353, 337–343, doi:10.1016/j.bbrc.2006.12.035 (2007).
Saika, S. TGFbeta pathobiology in the eye. Laboratory investigation; a journal of technical methods and pathology 86, 106–115, doi:10.1038/labinvest.3700375 (2006).
Cousins, S. W., McCabe, M. M., Danielpour, D. & Streilein, J. W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Investigative ophthalmology & visual science 32, 2201–2211 (1991).
Acknowledgements
This study was supported by the National Natural Science Foundation of China (81370996, 81670839) and the Innovation Project of Shandong Academy of Medical Sciences.
Author information
Authors and Affiliations
Contributions
Y.H. designed the experiments. L.Z., Y.W., W.L. and Z.L. performed the experiments. L.Z., Y.W., W.L., P.A.T. and Y.H. analysed the data. L.Z. and W.L. wrote the manuscript. L.X. and Y.H. reviewed and approved the manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, L., Wang, Y., Li, W. et al. MicroRNA-30a Regulation of Epithelial-Mesenchymal Transition in Diabetic Cataracts Through Targeting SNAI1. Sci Rep 7, 1117 (2017). https://doi.org/10.1038/s41598-017-01320-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-01320-3
- Springer Nature Limited
This article is cited by
-
SP1 promotes high glucose-induced lens epithelial cell viability, migration and epithelial-mesenchymal transition via regulating FGF7 and PI3K/AKT pathway
International Ophthalmology (2024)
-
MicroRNA-204-5p Attenuates Oxidative Stress, Apoptosis and Inflammation by Targeting TXNIP in Diabetic Cataract
Biochemical Genetics (2024)
-
Let-7c-3p suppresses lens epithelial-mesenchymal transition by inhibiting cadherin-11 expression in fibrotic cataract
Molecular and Cellular Biochemistry (2024)
-
Long non-coding RNA nuclear paraspeckle assembly transcript 1 downregulation protects lens epithelial cells from oxidative stress-induced apoptosis by regulating the microRNA-124-3p/death-associated protein kinase 1 axis in age-related cataract
International Ophthalmology (2023)
-
The interaction between autophagy and the epithelial-mesenchymal transition mediated by NICD/ULK1 is involved in the formation of diabetic cataracts
Molecular Medicine (2022)